BONE BIOLOGICS CORP (BBLG) Stock Analyst Ratings
USA - NASDAQ:BBLG - US0980706008 - Common Stock
2.16 USD
-0.08 (-3.57%)
ChartMill assigns a Buy % Consensus number of 83% to BBLG. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.95. This target is 962.5% above the current price.
BBLG was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BBLG.
In the previous month the buy percentage consensus was at a similar level.
BBLG was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-13 | EF Hutton | Reiterate | Buy |
| 2023-04-03 | EF Hutton | Reiterate | Buy |
| 2022-10-18 | EF Hutton | Initiate | Buy |
BONE BIOLOGICS CORP / BBLG FAQ
What do analysts expect the price target to be for BONE BIOLOGICS CORP (BBLG)?
7 analysts have analysed BBLG and the average price target is 22.95 USD. This implies a price increase of 962.5% is expected in the next year compared to the current price of 2.16.
What is the consensus rating for BBLG stock?
The consensus rating for BONE BIOLOGICS CORP (BBLG) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for BONE BIOLOGICS CORP stock?
The number of analysts covering BONE BIOLOGICS CORP (BBLG) is 7.